Clinical Trial Update: The Impact of the "WOMAN-PRO II Program" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial completed evaluating the WOMAN-PRO II program's impact on post-surgical symptom prevalence in patients with vulvar cancer and vulvar intr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvar Cancer
• Vulvar Intraepithelial Neoplasia

Snippet

Sponsor: St.Gallen University of Applied Sciences | Conditions: Vulvar Cancer, Vulvar Intraepithelial Neoplasia | Phase 2 | Status: COMPLETED